Relationship between CCR5 density and viral load after discontinuation of antiretroviral therapy

被引：15

作者：

Reynes, J ^{[1
]}

Baillat, V

Portales, P

Clot, J

Corbeau, P

机构：

[1] Hop Gui de Chauliac, Serv Malad Infect & Trop, Montpellier, France

[2] Hop St Eloi, Immunol Lab, Montpellier, France

[3] Inst Human Genet, Montpellier, France

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2004年 / 291卷 / 01期

关键词：

D O I：

10.1001/jama.291.1.46

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：46 / 46

页数：1

共 5 条

[1] Cell surface CCR5 density determines the postentry efficiency of R5 HIV-1 infection [J].

Lin, YL ;

Mettling, C ;

Portales, P ;

Reynes, J ;

Clot, J ;

Corbeau, P .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (24) :15590-15595

[2] Structured treatment interruptions to control HIV-1 and limit drug exposure [J].

Montaner, LJ .

TRENDS IN IMMUNOLOGY, 2001, 22 (02) :92-96

[3] Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection [J].

Oxenius, A ;

Price, DA ;

Günthard, HF ;

Dawson, SJ ;

Fagard, C ;

Perrin, L ;

Fischer, M ;

Weber, R ;

Plana, M ;

García, F ;

Hirschel, B ;

McLean, A ;

Phillips, RE .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (21) :13747-13752

[4] CD4+ T cell surface CCR5 density as a determining factor of virus load in persons infected with human immunodeficiency virus type 1 [J].

Reynes, J ;

Portales, P ;

Segondy, M ;

Baillat, V ;

André, P ;

Réant, B ;

Avinens, O ;

Couderc, G ;

Benkirane, M ;

Clot, J ;

Eliaou, JF ;

Corbeau, P .

JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (03) :927-932

[5] CD4 T cell surface CCR5 density as a host factor in HIV-1 disease progression [J].

Reynes, J ;

Portales, P ;

Segondy, M ;

Baillat, V ;

André, P ;

Avinens, O ;

Picot, MC ;

Clot, J ;

Eliaou, JF ;

Corbeau, P .

AIDS, 2001, 15 (13) :1627-1634

← 1 →